Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma
Original Article
I.K. Mellinghoff, M.J.v.d. Bent, D.T. Blumenthal, M. Touat, K.B. Peters, J. Clarke, J. Mendez, S. Yust-Katz, L. Welsh, W.P. Mason, F. Ducray, Y. Umemura, B. Nabors, M. Holdhoff, A.F. Hottinger, Y. Arakawa, J.M. Sepulveda, W. Wick, R. Soffietti, J.R. Perry, P. Giglio, M.d.l. Fuente, E.A. Maher, S. Schoenfeld, D. Zhao, S.S. Pandya, L. Steelman, I. Hassan, P.Y. Wen, and T.F. Cloughesy
N Engl J Med 2023;389:589-601
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation